IRONWOOD PHARMACEUTICALS, INC. Total Assets
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Total Assets of $285.13 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-06
- 2026-06-30: Assets $285.13M.
- 2026-03-31: Assets $434.57M.
- 2025-12-31: Assets $396.90M.
- 2025-09-30: Assets $396.06M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $285.13M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $434.57M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $396.90M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $396.06M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $342.95M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $327.21M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $350.91M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $389.52M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $395.62M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $438.82M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $471.07M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $524.06M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $603.22M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.16B 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $1.10B 10-K · filed 2024-02-16 | |
| 2022-09-30 | $1.04B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $975.69M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.08B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.13B 10-K · filed 2023-02-16 | |
| 2021-09-30 | $1.08B 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.01B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $599.34M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $559.24M 10-K · filed 2022-02-18 | |
| 2020-09-30 | $492.32M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $443.54M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $404.00M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $402.75M 10-K · filed 2021-02-17 | |
| 2019-09-30 | $334.34M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $315.72M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $363.54M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $332.05M 10-K · filed 2020-02-13 | |
| 2018-09-30 | $416.65M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $618.22M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $571.10M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $605.67M 10-K · filed 2019-02-25 | |
| 2017-09-30 | $625.09M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $705.08M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $701.32M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $709.82M 10-K · filed 2018-02-22 | |
| 2016-09-30 | $731.98M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $700.21M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $603.33M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $619.12M 10-K · filed 2017-02-22 | |
| 2015-09-30 | $613.43M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $653.94M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $305.53M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $329.32M 10-K · filed 2016-02-19 | $333.51M 10-K · filed 2015-02-18 |
| 2014-09-30 | $346.17M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $371.06M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $418.87M 10-Q · filed 2014-04-29 | |
| 2013-12-31 | $278.96M 10-K · filed 2015-02-18 | |
| 2013-09-30 | $325.84M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $384.03M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $325.09M 10-Q · filed 2013-04-23 | |
| 2012-12-31 | $229.91M 10-K · filed 2014-02-07 | |
| 2012-09-30 | $246.52M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $208.66M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $249.18M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $208.98M 10-K · filed 2013-02-21 | |
| 2011-09-30 | $219.48M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $249.73M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $301.37M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |